Search

everythinglearnresearchcommunity

for

Search:↓

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Alopecia areata may be linked to higher heart disease risk.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Vitamin D is crucial for bone health and preventing serious diseases.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Two young siblings experienced hair loss without hormone issues or other skin problems.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Pellagra, caused by niacin deficiency and presenting with photosensitivity, should be considered in patients with relevant symptoms and risk factors.

A woman showed neurological symptoms from psittacosis linked to bird exposure, improving after antibiotic treatment.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Two children grew extra hair from taking omeprazole, which went away after they stopped the medication.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Premature graying of hair is often linked with other health issues, but treatment with biotin, zinc, and calcium pantothenate is not very effective.

People with alopecia areata often have lower levels of zinc and vitamin D.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document explains various skin conditions and their treatments.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Alopecia areata treatment varies, with no optimal method established yet.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.